Groundbreaking UK “mega-trial” will test existing drugs as new treatments for MS
In a world-first “mega-trial”, UK experts will test a range of drugs already approved for other illnesses for the treatment…
In association with Teckro
In a world-first “mega-trial”, UK experts will test a range of drugs already approved for other illnesses for the treatment…
Canadian firm Arch Biopartners has secured approval to make certain protocol amendments to the Phase II trial of its lead…
In the digital era, we have gotten used to searching and retrieving almost any information we require within seconds. Because people asked “what if?”, we…
Drug development is extremely challenging no matter the condition – nine in ten drugs fail in clinical trials. However, this worrying situation is even more…